Papers: 10.1038/s41598-020-71263-9

https://doi.org/10.1038/s41598-020-71263-9

Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer

Cited by: 7
Author(s): Sabina Luszczak, Benjamin S. Simpson, Urszula Stopka‐Farooqui, Vignesh Krishna Sathyadevan, Lina María Carmona Echeverría, Christopher Kumar, Helena Costa, Aiman Haider, Alex Freeman, Charles Jameson, Marzena Ratyńska, Imen Ben‐Salha, Ashwin Sridhar, Greg Shaw, John D. Kelly, Hayley Pye, Kathy Gately, Hayley C. Whitaker, Susan Heavey
Published: about 6 years ago

Software Mentions 2